These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33529322)

  • 1. Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
    Zhang Y; Shen L; Dreißigacker K; Zhu H; Trinh-Minh T; Meng X; Tran-Manh C; Dees C; Matei AE; Chen CW; Ditschkowski M; Krauss S; Winkler J; Wolff D; Ziemer M; Beilhack A; Karrer S; Herr W; Mackensen A; Schett G; Spriewald BM; Distler JHW
    Blood; 2021 Apr; 137(17):2403-2416. PubMed ID: 33529322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease.
    Zerr P; Palumbo-Zerr K; Distler A; Tomcik M; Vollath S; Munoz LE; Beyer C; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
    Blood; 2012 Oct; 120(14):2909-17. PubMed ID: 22915638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.
    Zerr P; Distler A; Palumbo-Zerr K; Tomcik M; Vollath S; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
    Am J Pathol; 2012 Nov; 181(5):1672-80. PubMed ID: 22940072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
    Chen CW; Beyer C; Liu J; Maier C; Li C; Trinh-Minh T; Xu X; Cole SH; Hsieh MH; Ng N; Althage A; Meeusen S; Pan S; Svensson EC; Seidel HM; Schett G; Gergely P; Harris JL; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):773-778. PubMed ID: 28153829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice.
    Radojcic V; Paz K; Chung J; Du J; Perkey ET; Flynn R; Ivcevic S; Zaiken M; Friedman A; Yan M; Pletneva MA; Sarantopoulos S; Siebel CW; Blazar BR; Maillard I
    Blood; 2018 Nov; 132(20):2188-2200. PubMed ID: 30181175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.
    Matsushita T; Date M; Kano M; Mizumaki K; Tennichi M; Kobayashi T; Hamaguchi Y; Hasegawa M; Fujimoto M; Takehara K
    Am J Pathol; 2017 Apr; 187(4):841-850. PubMed ID: 28189565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
    Kavian N; Marut W; Servettaz A; Laude H; Nicco C; Chéreau C; Weill B; Batteux F
    J Immunol; 2012 May; 188(10):5142-9. PubMed ID: 22491256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
    Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic graft-versus-host disease with bortezomib.
    Pai CC; Chen M; Mirsoian A; Grossenbacher SK; Tellez J; Ames E; Sun K; Jagdeo J; Blazar BR; Murphy WJ; Abedi M
    Blood; 2014 Sep; 124(10):1677-88. PubMed ID: 25009225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes.
    Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H
    Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
    Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
    Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.
    Fransolet G; Ehx G; Somja J; Delens L; Hannon M; Muller J; Dubois S; Drion P; Caers J; Humblet-Baron S; Delvenne P; Beguin Y; Conteduca G; Baron F
    J Hematol Oncol; 2016 Jul; 9(1):53. PubMed ID: 27377819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.
    Beyer C; Schramm A; Akhmetshina A; Dees C; Kireva T; Gelse K; Sonnylal S; de Crombrugghe B; Taketo MM; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2012 May; 71(5):761-7. PubMed ID: 22328737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
    Bergmann C; Akhmetshina A; Dees C; Palumbo K; Zerr P; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Dec; 70(12):2191-8. PubMed ID: 21873331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tankyrase inhibitor G007-LK inhibits small intestine LGR5
    Norum JH; Skarpen E; Brech A; Kuiper R; Waaler J; Krauss S; Sørlie T
    Biol Res; 2018 Jan; 51(1):3. PubMed ID: 29316982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
    Lu W; Li Y
    J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.